Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Ferrajoli

Showing results (1-10 of 353) with videos related to

Pageof 36
Sort By:
Haematologica|October 13, 2005
Bendamustine in relapsed or refractory chronic lymphocytic leukemiaAlessandra Ferrajoli
Hematology. American Society of Hematology. Education Program|January 18, 2011
Treatment of younger patients with chronic lymphocytic leukemiaAlessandra Ferrajoli
Leukemia & Lymphoma|May 9, 2012
Interfering with CD40 ligation: a sensitive matter in chronic lymphocytic leukemiaAlessandra Ferrajoli
Leukemia & Lymphoma|April 7, 2009
Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemiaAlessandra Ferrajoli
Current Oncology Reports|April 2, 2022
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New TherapiesDaniel Rivera, Alessandra Ferrajoli
Drugs & Aging|May 6, 2019
Treating Older Patients with Chronic Lymphocytic Leukemia: A Personalized ApproachPaolo Strati, Alessandra Ferrajoli
Haematologica|January 2, 2019
Lenalidomide can be safely combined with chlorambucil and rituximab in older patients with chronic lymphocytic leukemiaCandida Vitale, Alessandra Ferrajoli
Current Hematologic Malignancy Reports|February 24, 2018
Prognostic Factors in the Era of Targeted Therapies in CLLPrajwal Boddu, Alessandra Ferrajoli
Expert Review of Hematology|July 24, 2020
The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemiaCandida Vitale, Alessandra Ferrajoli
Current Hematologic Malignancy Reports|February 3, 2016
Richter Syndrome in Chronic Lymphocytic LeukemiaCandida Vitale, Alessandra Ferrajoli
Pageof 36

Showing results (1-10 of 353) with videos related to

Sort By:
Pageof 36
Haematologica|October 13, 2005
Bendamustine in relapsed or refractory chronic lymphocytic leukemiaAlessandra Ferrajoli
Hematology. American Society of Hematology. Education Program|January 18, 2011
Treatment of younger patients with chronic lymphocytic leukemiaAlessandra Ferrajoli
Leukemia & Lymphoma|May 9, 2012
Interfering with CD40 ligation: a sensitive matter in chronic lymphocytic leukemiaAlessandra Ferrajoli
Leukemia & Lymphoma|April 7, 2009
Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemiaAlessandra Ferrajoli
Current Oncology Reports|April 2, 2022
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New TherapiesDaniel Rivera, Alessandra Ferrajoli
Drugs & Aging|May 6, 2019
Treating Older Patients with Chronic Lymphocytic Leukemia: A Personalized ApproachPaolo Strati, Alessandra Ferrajoli
Haematologica|January 2, 2019
Lenalidomide can be safely combined with chlorambucil and rituximab in older patients with chronic lymphocytic leukemiaCandida Vitale, Alessandra Ferrajoli
Current Hematologic Malignancy Reports|February 24, 2018
Prognostic Factors in the Era of Targeted Therapies in CLLPrajwal Boddu, Alessandra Ferrajoli
Expert Review of Hematology|July 24, 2020
The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemiaCandida Vitale, Alessandra Ferrajoli
Current Hematologic Malignancy Reports|February 3, 2016
Richter Syndrome in Chronic Lymphocytic LeukemiaCandida Vitale, Alessandra Ferrajoli
Pageof 36